Related Experiment Video
Updated: Aug 15, 2026
10:53
Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions
Published on: October 10, 2016
Budesonide modified-release capsules
1College of Pharmacy, Washington State University, Spokane, WA, USA.
Reviews in Gastroenterological Disorders
|July 18, 2002
Summary
Budesonide modified-release capsules effectively treat Crohn
Area of Science:
- Gastroenterology
- Pharmacology
- Internal Medicine
Background:
- Crohn's disease is a chronic inflammatory bowel disease.
- Budesonide is a corticosteroid with local anti-inflammatory effects.
- Current therapies have limitations in efficacy and side effect profiles.
Purpose of the Study:
- To evaluate the efficacy of budesonide modified-release capsules for Crohn's disease.
- To compare budesonide with existing therapies like prednisolone and prednisone.
- To assess the adverse reaction profile of budesonide compared to other corticosteroids.
Main Methods:
- Treatment with budesonide modified-release capsules.
- Assessment of therapeutic effectiveness in specific regions of the gastrointestinal tract (distal ileum, ileocecal region, ascending colon).
- Comparison of budesonide with prednisolone and prednisone in active Crohn's disease.
Main Results:
- Budesonide modified-release capsules are effective for Crohn's disease in the distal ileum, ileocecal region, and ascending colon.
- Budesonide is less effective for extensive or left-sided colitis due to its local action.
- Budesonide demonstrates comparable or lesser efficacy than prednisolone/prednisone but with fewer glucocorticoid-related adverse reactions.
Conclusions:
- Budesonide modified-release capsules offer an effective, localized treatment option for specific presentations of Crohn's disease.
- The favorable side effect profile makes budesonide a valuable alternative to systemic corticosteroids for certain patients.
- Treatment selection should consider disease location and the balance between efficacy and adverse effects.
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...